US FDA asks 5 firms to recall diabetes drug with high levels of probable carcinogen
US FDA asks 5 firms to recall diabetes drug with high levels of probable carcinogen The agency said the drugs contained the probable carcinogen N-nitrosodimethylamine (NDMA) beyond acceptable limits in their extended-release formulations alone. https://ift.tt/eA8V8J
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment